Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cirrus Pharmaceuticals, a Kemwell company, has announced that Andrew Hamer has joined as VP R&D.
read more
Wednesday, August 19, 2015
Boehringer Ingelheim has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European label for Giotrif®.
read more
Wednesday, August 19, 2015
Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC.
read more
Wednesday, August 19, 2015
Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked.
read more
Wednesday, August 19, 2015
Amneal Pharmaceuticals has announced the launch of aripiprazole oral solution in 1 mg/mL strength.
read more
Wednesday, August 19, 2015
The FDA has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
read more
Wednesday, August 26, 2015
Recipharm AB has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105.
read more
Wednesday, August 26, 2015
BioPharma Services has announced that its Toronto-based Bioanalytical Laboratory has successfully passed its first inspection by the Brazilian regulatory authority, ANVISA.
read more
Wednesday, August 26, 2015
Laboratory Corporation of America Holdings has announced that Covance Drug Development has received a multi-year award from a leading pharmaceutical company to use Covance’s Xcellerate® platform as an exclusive central monitoring solution for their ...
read more
Wednesday, August 26, 2015
IDT Biologika announces today the acquisition of Gallant Custom Laboratories, based in Ontario, Canada. The transaction is to close August 31, 2015.
read more
Wednesday, August 26, 2015
Amneal has announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals.
read more
Wednesday, August 26, 2015
Alvogen has entered into a definitive agreement with Pfizer under which it will acquire a portfolio of four pharmaceutical products.
read more
MPI Research and Exemplar Genetics today announced the first successful validation of a new genetically engineered miniature pig model, offering an attractive alternative to rodent models, of atherosclerosis. The ExeGen® LDLR miniswine is a pig model...
read more
Wednesday, September 02, 2015
AstraZeneca has announced positive topline results from RECAPTURE 1 and RECAPTURE 2, the pivotal Phase III studies evaluating the antibiotic, CAZ-AVI (ceftazidime-avibactam), as a treatment for adult hospitalized patients with complicated Urinary ...
read more
Wednesday, September 02, 2015
Novartis has entered into a global collaboration with Amgen to commercialize and develop pioneering neuroscience treatments.
read more